ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
The Diamyd Story
CEO Comments
Board & Management
Scientific Advisory Board
Corporate Governance
Annual General Meeting
Board & Management
Auditors
Articles of Incorporation
Remuneration Principles
Incentive Programs
Partnering
Contact Us
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
GAD platform
Diamyd
®
Diamyd
®
in Type 1
Diamyd
®
in LADA
Order GAD for research
CLINICAL TRIALS
CLINICAL TRIALS
Clinical development
Diabetes Clinical Trials
Drug Development
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
Calendar
Owners
Share Trading
Insider Trading
Company Description
Shares Issue
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Scientific publications
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
Press Room
»
Press Releases
Press Releases
Svenska
English
2013
Former Diamyd Medical
Data pager
1
Show items per page:
PageSizeComboBox
select
10
20
50
100
150
6 records in 1 pages
6/13/2013
Diamyd expands its Scientific Advisory Board
5/28/2013
Diamyd implements rights issue of approximately MSEK 21 to fund expanded diabetes portfolio
5/17/2013
Chairman increases holdings in Diamyd
5/15/2013
New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013
5/14/2013
Diamyd broadens the diabetes portfolio
4/22/2013
Diamyd spins out the subsidiary Diamyd Therapeutics which changes name to Diamyd Medical
Press Room
Press Releases
News & Mediawatch
Scientific publications
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Related links
Follow us on Twitter